Table 1.
Characteristics of 1726 nonsevere patients with COVID-19.
| Parameters | Total∗ (N = 1726) | NSCU∗ (n = 1212) | SCU∗ (n = 514) | P value† |
|---|---|---|---|---|
| Baseline characteristics | ||||
| Age (years) | 55 (39-66) | 56 (41-67) | 51 (37-64) | <.001 |
| Laboratory test | ||||
| White blood cell count (109/liter) | 5.30 (4.10-6.64) | 5.41 (4.28-6.64) | 4.95 (3.55-6.63) | .1642 |
| Albumin(g/liter) | 39.80 (36.50-42.90) | 39.90 (36.60-43.00) | 39.60 (36.20-42.70) | .3659 |
| C-reaction protein (mg/liter) | 4.60 (1.00-22.30) | 2.60 (0.70-13.96) | 14.65 (4.25-38.10) | <.001 |
| Sex | .006 | |||
| Female | 940 (54.46) | 686 (56.60) | 254 (49.42) | |
| Male | 786 (45.54) | 526 (43.40) | 260 (50.58) | |
| Symptom | ||||
| Cough | 799 (46.29) | 561 (46.29) | 238 (46.30) | .995 |
| Fever | 1041 (60.31) | 659 (54.37) | 382 (74.32) | <.001 |
| Anhelation | 164 (9.50) | 127 (10.48) | 37 (7.20) | .034 |
| Comorbidity | ||||
| Hypertension | 539 (31.23) | 384 (31.68) | 155 (30.16) | .531 |
| Malignancy | 96 (5.56) | 56 (4.62) | 40 (7.78) | .009 |
| Diabetes | 258 (14.95) | 183 (15.10) | 75 (14.59) | .787 |
| COPD | 104 (6.03) | 74 (6.11) | 30 (5.84) | .830 |
| Coronary heart disease | 145 (8.40) | 99 (8.17) | 46 (8.95) | .593 |
| Treatment | ||||
| Antivirus drugs | 1526 (88.41) | 1036 (85.48) | 490 (95.33) | <.001 |
| NSAID | 481 (27.87) | 231 (19.06) | 250 (48.64) | <.001 |
| Antibiotic drugs | 1231 (71.32) | 742 (61.22) | 489 (95.14) | <.001 |
| Outcomes | ||||
| Length of stay (days) | 16 (10-24) | 14 (9-20) | 22 (14-30) | <.001 |
| Progression to severe type (30 days) | 509 (29.49) | 328 (27.06) | 181 (35.21) | <.001 |
| All-cause death (30 days) | 43 (2.49) | 25 (2.06) | 18 (3.50) | .079 |
COPD indicates chronic obstructive pulmonary disease; NSAID, nonsteroidal anti-inflammatory drug; NSCU, nonsystemic corticosteroid use; SCU, systemic corticosteroid use.
∗
Categorical variables are presented as number (percent), and continuous variables are presented as median (interquartile range).
†
P values indicate differences between the NSCU and SCU groups.